SI-BONE, Inc.
SIBNSI-BONE is a medical device leader specializing in innovative procedural solutions for compromised bone, with a primary focus on the sacroiliac (SI) joint.
Earnings
Next report
Aug 3, 2026 (In 5 days)Valuation & ratios
Competitors
By market cap
By revenue growth
Profile
SI-BONE is a medical device leader specializing in innovative procedural solutions for compromised bone, with a primary focus on the sacroiliac (SI) joint. The company leverages additive manufacturing and biomechanical design to provide minimally invasive treatments for SI joint dysfunction, pelvic trauma, and thoracolumbar spinal fixation. Their value proposition is centered on a robust portfolio of 3D-printed titanium implants supported by extensive clinical evidence and randomized controlled trials.
A pioneer and market leader in minimally invasive SI joint fusion with significant clinical data barriers and multiple FDA breakthrough device designations.
Questions, answered.
- What is SI-BONE, Inc.'s market cap?
- SI-BONE, Inc. (SIBN) has a market capitalization of $756.2M and trades on NASDAQ.
- What is SI-BONE, Inc.'s revenue and profitability?
- SI-BONE, Inc. generated $206.2M in trailing twelve-month revenue with a net loss of $16.7M, representing a net margin of -8.1%. Gross margin stands at 79.6%, with free cash flow of -$6.0M. These figures are based on the Q1 2026 filing.
- Who are SI-BONE, Inc.'s competitors?
- SI-BONE, Inc.'s key competitors include Tenon Medical, Inc., Globus Medical, Inc., Alphatec Holding Inc., and others. These companies compete in similar markets and product categories.
- Where is SI-BONE, Inc. headquartered?
- SI-BONE, Inc. is headquartered in United States of America and employs approximately 344 people. It has been publicly traded since 2018.
